| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |